课题基金 / 基金详情

Influence of Psychosis on Brain-Behavior Endophenotypes for Bipolar Disorder

Influence of Psychosis on Brain-Behavior Endophenotypes for Bipolar Disorder
精神病对双相情感障碍脑行为内表型的影响
批准号:
8241065
负责人:
DAVID C GLAHN
金额:
$42.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2014-07-31

项目摘要

项目成果

DAVID C GLAHN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The aims in this study will (1) develop candidate neurocognitive and neuroimaging endophenotypes for bipolar I disorder (BPI), (2) examine the association of history of psychosis and these brain-behavior markers in BPI patients, and (3) determine if markers are sensitive to liability for psychosis. Thus, the project has two overlapping goals: the development of candidate endophenotypes for BPI broadly and the identification of candidate endophenotypes for psychosis. The ultimate promise of this research is to develop markers that will characterize the biological mechanisms of BPI and facilitate the discovery of genes that predispose the illness. We believe that a comprehensive assessment of neuropsychological functioning and brain structure and function in sibling pairs discordant for bipolar disorder and stratified for psychosis history is a strategically strong first step towards reaching these goals. To this end, we will perform anatomic and functional neuroimaging and conduct neuropsychological examinations on 130 euthymic patients with BPI (65 with history of psychosis), 130 of their unaffected same-sex siblings and 65 unrelated comparison subjects. Markers found to be aberrant in both affected individuals (regardless of history of psychosis) and in their unaffected relatives will be considered candidate endophenotypes for BPI (Aim 1). Neuropsychological and neuroimaging measures that distinguish between BPI patients with and without history of psychosis (Aim 2) and their siblings (Aim 3) will be considered potential endophenotypes for psychosis. Bipolar I disorder represents a significant economic burden and is associated with substantial morbidity and mortality rates. Although it is well established that BPI is substantially heritable, the molecular genetic basis for this illness remains elusive, potentially because of illness complexity, heterogeneity of disease expression, and comorbidity with other disorders that may distort clinical presentation. In the face of evidence that genes predisposing to BPI may be transmitted without expression of the clinical phenotype, interest has arisen in developing endophenotypes for the illness, indicators of processes mediating between genotype and phenotype. Given the high rates of psychosis in BPI and that history of psychosis may alter brain structure and function, we believe that elucidating neurocognitive and neuroimaging endophenotypes for the disorder must account for the potential impact of hallucinations and delusions on these markers. This research will established biomarkers that could improve the identification and treatment of BPI patients and, potentially, patients with psychotic disorders, independent of their formal diagnosis. PUBLIC HEALTH RELEVANCE: Bipolar I disorder is a major public health burden whose biology is still largely unknown. Through the development of brain-behavior markers sensitive to genetic liability for bipolar disorder, the proposed research should significantly aid the discovery of genes that predispose the illness and facilitate the identification of the biological determinants of bipolar disorder. This, in turn, should lead to improved characterization and treatment of bipolar disorder.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.biopsych.2013.01.027
发表时间: 2013-08-15
期刊: BIOLOGICAL PSYCHIATRY
影响因子: 10.6
作者: [Whalley, Heather C., Sprooten, Emma, Hackett, Suzanna, Hall, Lynsey, Blackwood, Douglas H., Glahn, David C., Bastin, Mark, Hall, Jeremy, Lawrie, Stephen M., Sussmann, Jessika E., McIntosh, Andrew M.]
通讯作者: McIntosh, Andrew M.
DOI: 10.1176/appi.ajp.2017.17010095
发表时间: 2017-12-01
期刊: The American journal of psychiatry
影响因子: --
作者: [Doucet GE, Bassett DS, Yao N, Glahn DC, Frangou S]
通讯作者: Frangou S
DOI: 10.1038/s41380-018-0228-9
发表时间: 2020-09
期刊: Molecular psychiatry
影响因子: 11
作者: [Nunes A, Schnack HG, Ching CRK, Agartz I, Akudjedu TN, Alda M, Alnæs D, Alonso-Lana S, Bauer J, Baune BT, Bøen E, Bonnin CDM, Busatto GF, Canales-Rodríguez EJ, Cannon DM, Caseras X, Chaim-Avancini TM, Dannlowski U, Díaz-Zuluaga AM, Dietsche B, Doan NT, Duchesnay E, Elvsåshagen T, Emden D, Eyler LT, Fatjó-Vilas M, Favre P, Foley SF, Fullerton JM, Glahn DC, Goikolea JM, Grotegerd D, Hahn T, Henry C, Hibar DP, Houenou J, Howells FM, Jahanshad N, Kaufmann T, Kenney J, Kircher TTJ, Krug A, Lagerberg TV, Lenroot RK, López-Jaramillo C, Machado-Vieira R, Malt UF, McDonald C, Mitchell PB, Mwangi B, Nabulsi L, Opel N, Overs BJ, Pineda-Zapata JA, Pomarol-Clotet E, Redlich R, Roberts G, Rosa PG, Salvador R, Satterthwaite TD, Soares JC, Stein DJ, Temmingh HS, Trappenberg T, Uhlmann A, van Haren NEM, Vieta E, Westlye LT, Wolf DH, Yüksel D, Zanetti MV, Andreassen OA, Thompson PM, Hajek T, ENIGMA Bipolar Disorders Working Group]
通讯作者: ENIGMA Bipolar Disorders Working Group
Conceptualizing impulsivity and risk taking in bipolar disorder: importance of history of alcohol abuse.
概念化冲动性和风险服用双相情感障碍:酗酒史的重要性。
DOI: 10.1111/j.1399-5618.2008.00657.x
发表时间: 2009-02
期刊: Bipolar disorders
影响因子: 5.4
作者: [Kathleen Holmes M, Bearden CE, Barguil M, Fonseca M, Serap Monkul E, Nery FG, Soares JC, Mintz J, Glahn DC]
通讯作者: Glahn DC
6
    Translational Post-doctoral Training in Neurodevelopment
    • 批准号:
      10411050
    • 项目类别:
    • 资助金额:
      $19.37万
    • 财政年份:
      2017
    • 负责人:
      DAVID C GLAHN
    • 依托单位:
    Translational Post-doctoral Training in Neurodevelopment
    • 批准号:
      10650880
    • 项目类别:
    • 资助金额:
      $29.15万
    • 财政年份:
      2017
    • 负责人:
      DAVID C GLAHN
    • 依托单位:
    1/3:Pedigree-Based Whole Genome Sequencing of Affective and Psychotic Disorders
    • 批准号:
      9228398
    • 项目类别:
    • 资助金额:
      $36.38万
    • 财政年份:
      2015
    • 负责人:
      DAVID C GLAHN
    • 依托单位:
    1/3:Pedigree-Based Whole Genome Sequencing of Affective and Psychotic Disorders
    • 批准号:
      9024625
    • 项目类别:
    • 资助金额:
      $28.2万
    • 财政年份:
      2015
    • 负责人:
      DAVID C GLAHN
    • 依托单位:
    海外基金